Bringing Value To The Care Pathway: The Rising Role Of Rapid Diagnostics

Decorative image of the AMR Learning Lounge

Bringing Value To The Care Pathway: The Rising Role Of Rapid Diagnostics

SUMMARY

This new briefing from CIDRAP-ASP explores how outcomes research (OR) can build a value case for rapid diagnostics in the fight against antimicrobial resistance (AMR) and in support of effective antimicrobial stewardship (AMS), including "recommendations for applying outcomes research to the study, use, and policy of rapid diagnostics in healthcare." In recent years, we have witnessed what commitment and investment can achieve in the rapid development and uptake of diagnostic tools. Perhaps OR could spur enthusiasm and momentum in your healthcare system and community as we look to slow the spread of AMR.

*This work was funded by a grant from bioMérieux.

GET STARTED

Read the latest briefing on Outcomes Research & AMR from CIDRAP-ASP

Take Me There Now

Read time: 35 minutes

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.

Take Our Poll

Global Solutions

Antimicrobial Stewardship Solutions

Antimicrobial Resistance is undermining modern medicine and putting patients at risk of premature death. bioMérieux is committed to preserving antibiotic efficacy with the right diagnostic tests that guide appropriate and responsible use of antibiotics to ensure they remain lifesaving for posterity.

Learn More